Nina Johnston Selected Research

Troponin I

5/2015	Two-hour diagnostic algorithms for early assessment of patients with acute chest pain--Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile.
9/2014	Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender.
9/2009	Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
2/2006	Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.
6/2003	Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nina Johnston Research Topics

Disease

11	Acute Coronary Syndrome 01/2017 - 02/2005
9	Myocardial Infarction 01/2021 - 02/2005
9	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 06/2003
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2007 - 06/2003
3	ST Elevation Myocardial Infarction 01/2018 - 12/2013
3	Chest Pain (Chest Pains) 05/2015 - 02/2007
3	Heart Failure 02/2007 - 05/2004
2	Non-ST Elevated Myocardial Infarction 01/2017 - 05/2015
1	Atherosclerosis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Necrosis 01/2021
1	Unstable Angina 01/2017
1	Stable Angina 01/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2009
1	Ischemia 02/2007
1	Reperfusion Injury 02/2007
1	Coronary Disease (Coronary Heart Disease) 02/2006

Drug/Important Bio-Agent (IBA)

6	Dalteparin (Dalteparin Sodium)FDA Link 03/2008 - 06/2003
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2006
5	TroponinIBA 05/2015 - 05/2006
5	Troponin IIBA 05/2015 - 06/2003
4	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2007 - 05/2004
2	C-Reactive ProteinIBA 02/2007 - 02/2005
2	CreatinineIBA 02/2007 - 12/2006
2	Troponin T (Troponin T1)IBA 02/2007 - 02/2005
2	Growth Differentiation Factor 15IBA 02/2007 - 02/2007
2	oxidized low density lipoproteinIBA 11/2006 - 03/2006
2	HDL CholesterolIBA 03/2006 - 02/2006
2	pro-brain natriuretic peptide (1-76)IBA 02/2005 - 09/2004
1	AdipokinesIBA 01/2021
1	AldosteroneIBA 01/2021
1	ReninIBA 01/2021
1	AngiotensinsIBA 01/2021
1	trans-crotonin (CTN)IBA 05/2015
1	PTX3 proteinIBA 11/2013
1	SolutionsIBA 04/2013
1	Peroxidase (Myeloperoxidase)IBA 02/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2007
1	CytokinesIBA 02/2007
1	Immunoglobulin G (IgG)IBA 02/2007
1	tilisololIBA 05/2006
1	Triglycerides (Triacylglycerol)IBA 03/2006
1	LDL CholesterolIBA 03/2006
1	LipidsIBA 03/2006
1	HDL LipoproteinsIBA 03/2006
1	Lipoproteins (Lipoprotein)IBA 03/2006
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 03/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2006
1	CholesterolIBA 03/2006
1	Glucose (Dextrose)FDA LinkGeneric 02/2006
1	Thromboplastin (Tissue Factor)IBA 12/2005
1	DiureticsIBA 02/2005
1	NitratesIBA 02/2005
1	Natriuretic PeptidesIBA 09/2004
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2003

Therapy/Procedure

3	Therapeutics 01/2018 - 12/2013
2	Percutaneous Coronary Intervention 01/2017 - 12/2013
2	Secondary Prevention 01/2017 - 08/2016
1	Critical Care (Surgical Intensive Care) 12/2013